SYMLIN™ (pramlintide acetate) Unique Profile in Type 1 and Type 2 Diabetes
Placebo + Insulin ( Type 1, N=538 / Type 2, N=284)
SYMLIN™ Recommended Dose + Insulin (Type 1, N=716 / Type 2, N=292)
Combined data from pivotal studies, change from baseline at 26 weeks
* Statistically different from placebo